CN100448456C - 中国被毛孢浓缩型口服液 - Google Patents
中国被毛孢浓缩型口服液 Download PDFInfo
- Publication number
- CN100448456C CN100448456C CNB2006100406684A CN200610040668A CN100448456C CN 100448456 C CN100448456 C CN 100448456C CN B2006100406684 A CNB2006100406684 A CN B2006100406684A CN 200610040668 A CN200610040668 A CN 200610040668A CN 100448456 C CN100448456 C CN 100448456C
- Authority
- CN
- China
- Prior art keywords
- liquid
- pilose spore
- china pilose
- fermentation
- oral liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 83
- 230000001954 sterilising effect Effects 0.000 claims abstract description 14
- 238000012856 packing Methods 0.000 claims abstract description 9
- 238000000926 separation method Methods 0.000 claims abstract description 5
- 238000000855 fermentation Methods 0.000 claims description 45
- 230000004151 fermentation Effects 0.000 claims description 45
- 238000004519 manufacturing process Methods 0.000 claims description 25
- 241000190633 Cordyceps Species 0.000 claims description 20
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims description 12
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000001963 growth medium Substances 0.000 claims description 10
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 7
- 150000004676 glycans Chemical class 0.000 claims description 7
- 238000007689 inspection Methods 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 239000011550 stock solution Substances 0.000 claims description 7
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 6
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims description 6
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims description 6
- 229930195725 Mannitol Natural products 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 229960005305 adenosine Drugs 0.000 claims description 6
- 239000003797 essential amino acid Substances 0.000 claims description 6
- 235000020776 essential amino acid Nutrition 0.000 claims description 6
- 229940029575 guanosine Drugs 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 6
- 235000015073 liquid stocks Nutrition 0.000 claims description 6
- 239000000594 mannitol Substances 0.000 claims description 6
- 235000010355 mannitol Nutrition 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000011218 seed culture Methods 0.000 claims description 5
- 241000255789 Bombyx mori Species 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000005374 membrane filtration Methods 0.000 claims description 3
- 238000001223 reverse osmosis Methods 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 239000001888 Peptone Substances 0.000 claims description 2
- 108010080698 Peptones Proteins 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 229940023492 oral liquid product Drugs 0.000 claims description 2
- 235000019319 peptone Nutrition 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract description 4
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 238000011049 filling Methods 0.000 abstract description 3
- 210000003437 trachea Anatomy 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 206010039897 Sedation Diseases 0.000 abstract 1
- 230000000916 dilatatory effect Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000036280 sedation Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 12
- 241000233866 Fungi Species 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 230000003860 sleep quality Effects 0.000 description 6
- 240000001307 Myosotis scorpioides Species 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000000147 hypnotic effect Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 238000009423 ventilation Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000000703 high-speed centrifugation Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 235000020995 raw meat Nutrition 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FLNXBVJLPJNOSI-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 FLNXBVJLPJNOSI-UHFFFAOYSA-N 0.000 description 1
- 244000152526 Agathosma crenulata Species 0.000 description 1
- 235000013388 Agathosma crenulata Nutrition 0.000 description 1
- 235000009269 Barosma crenulata Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 241001264174 Cordyceps militaris Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- -1 al Species 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940062650 buchu Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960002544 cloperastine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- QUANRIQJNFHVEU-UHFFFAOYSA-N oxirane;propane-1,2,3-triol Chemical compound C1CO1.OCC(O)CO QUANRIQJNFHVEU-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000010117 shenhua Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100406684A CN100448456C (zh) | 2006-05-22 | 2006-05-22 | 中国被毛孢浓缩型口服液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100406684A CN100448456C (zh) | 2006-05-22 | 2006-05-22 | 中国被毛孢浓缩型口服液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1895294A CN1895294A (zh) | 2007-01-17 |
CN100448456C true CN100448456C (zh) | 2009-01-07 |
Family
ID=37608031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100406684A Expired - Fee Related CN100448456C (zh) | 2006-05-22 | 2006-05-22 | 中国被毛孢浓缩型口服液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100448456C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102835728A (zh) * | 2010-08-13 | 2012-12-26 | 内蒙古昆明卷烟有限责任公司 | 冬虫夏草有效成分在卷烟中的应用 |
CN103392513B (zh) * | 2013-08-14 | 2014-12-31 | 西藏现代农业有限公司 | 冬虫夏草菌丝体发酵物及其应用 |
CN104041809A (zh) * | 2014-06-11 | 2014-09-17 | 沈南英 | 一种冬虫夏草真菌发酵液酵素及其制备方法 |
CN105148029A (zh) * | 2015-07-08 | 2015-12-16 | 萧县创亿畜禽养殖农民专业合作社 | 一种冬虫夏草口服液的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1036531C (zh) * | 1994-08-25 | 1997-11-26 | 俞永信 | 冬虫夏草的深层发酵工艺 |
CN1055967C (zh) * | 1996-12-13 | 2000-08-30 | 张世伟 | 深层发酵法生产的冬虫夏草保健营养液 |
CN1478886A (zh) * | 2003-06-14 | 2004-03-03 | 安徽林苑虫草研究所 | 一种中国被毛孢液体菌种发酵工艺方法 |
-
2006
- 2006-05-22 CN CNB2006100406684A patent/CN100448456C/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1036531C (zh) * | 1994-08-25 | 1997-11-26 | 俞永信 | 冬虫夏草的深层发酵工艺 |
CN1055967C (zh) * | 1996-12-13 | 2000-08-30 | 张世伟 | 深层发酵法生产的冬虫夏草保健营养液 |
CN1478886A (zh) * | 2003-06-14 | 2004-03-03 | 安徽林苑虫草研究所 | 一种中国被毛孢液体菌种发酵工艺方法 |
Non-Patent Citations (2)
Title |
---|
膜分离技术及其在现代中药制剂中的应用研究. 徐波,王丽萍.天津药学,第17卷第3期. 2005 |
膜分离技术及其在现代中药制剂中的应用研究. 徐波,王丽萍.天津药学,第17卷第3期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN1895294A (zh) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108823125A (zh) | 一种治疗睡眠障碍益生菌制剂的生产方法及应用 | |
CN102389134A (zh) | 一种红茶菌复合发酵饮料及制备方法 | |
CN103211253A (zh) | 一种蓝莓红茶菌饮料及其制造方法 | |
CN108244432A (zh) | 一种发酵蛹虫草益生菌饮料及其制备方法 | |
CN1994116A (zh) | 生产淡豆豉的纯种发酵工艺 | |
CN106616165A (zh) | 一种玫瑰益生菌酵素饮品及其生产方法 | |
CN105166915A (zh) | 一种仙人掌红豆杉酵素制备方法 | |
CN100448456C (zh) | 中国被毛孢浓缩型口服液 | |
CN106234895A (zh) | 一种白刺果乳酸菌发酵饮料及其制备方法 | |
CN117158579A (zh) | 一种具有防脱发功效的黑枸杞发酵制品的应用 | |
CN1471952A (zh) | 中药多菌种混合发酵口服液的配制及其生产工艺 | |
CN107466860A (zh) | 一种红豆杉低聚果糖乳酸菌活性饮料及其制备方法 | |
CN110651936A (zh) | 一种利用蛹虫草发酵液配制保健饮料的方法 | |
CN106635681B (zh) | 一种猴头菇草莓配制酒的制备方法 | |
CN102813193A (zh) | 一种虫草花青口服液及其制备方法 | |
CN103103103B (zh) | 树莓饮料及其加工方法 | |
CN110547447A (zh) | 一种蜂王浆胶原蛋白水果酵素及其制作方法 | |
CN108142765A (zh) | 一种抗疲劳增强免疫力的蛹虫草复合酵素饮品制备方法 | |
CN1108691A (zh) | 一种红茶菌饮料及其酿制方法 | |
CN108085216A (zh) | 一种蜂蜜酒的加工方法 | |
CN106281865A (zh) | 一种纯树莓酒及其生产方法 | |
CN102994358A (zh) | 一种枇杷果醋和醋饮料及其酿造方法 | |
CN102488744A (zh) | 一种解酒毒的药物及其制备方法 | |
CN102440347A (zh) | 林蛙油功能肽及其发酵乳饮料制备方法 | |
CN103937649A (zh) | 用虫草轮枝菌和蛹虫草菌人工培制原生态虫草酒的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170122 Address after: 232000 Anhui province tianjia''an District Huainan City Economic Development Zone No. 6 standard workshop of the eastern half of the 1-3 layer Patentee after: Anhui Cordyceps Biotechnology Co., Ltd. Address before: 141 Hefei,, Anhui Agriculture University, No. 130 Changjiang Road, Anhui Patentee before: Anhui Agricultural Univ. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170908 Address after: 1009-5, building 230088, building F3, innovation industrial park, 2800 innovation road, Hefei hi tech Zone, Anhui Patentee after: Anhui Hui Zi Biological Technology Co., Ltd. Address before: 232000 Anhui province tianjia'an District Huainan City Economic Development Zone No. 6 standard workshop of the eastern half of the 1-3 layer Patentee before: Anhui Cordyceps Biotechnology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180102 Address after: 232000 Anhui province tianjia'an District Huainan City Economic Development Zone No. 6 standard workshop of the eastern half of the 1-3 layer Patentee after: Anhui Cordyceps Biotechnology Co., Ltd. Address before: 1009-5, building 230088, building F3, innovation industrial park, 2800 innovation road, Hefei hi tech Zone, Anhui Patentee before: Hui Zi biological Polytron Technologies Inc, Anhui |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090107 Termination date: 20210522 |
|
CF01 | Termination of patent right due to non-payment of annual fee |